Here’s the latest on RSV vaccine eligibility from reputable sources:
CDC in the United States updated guidelines to broaden eligibility for older adults. As of mid-2024, vaccination is recommended for adults 75 years and older, and for adults 60–74 years with certain high-risk health conditions. Some updates in 2025–2026 further expanded considerations for high-risk adults in their 50s and 60s, depending on health status. These changes reflect evolving evidence on risk reductions and safety monitoring.
In the UK, the RSV vaccination program expanded eligibility effective from early 2026. The NHS RSV program extended to include adults aged 75 and over who hadn’t previously received a dose, those aged 80+ with no upper age limit, and all care home residents, due to their higher vulnerability. This marks a broader reach beyond the prior 60–74 and 75+ cohorts.
General trend: health authorities are focusing on high-risk groups (age bands plus key comorbidities) and expanding access as more safety and effectiveness data become available. For exact eligibility in your area, check your local health department or official vaccine program website, as recommendations can differ by country and may have phased rollout specifics.
Key takeaways for you
If you’d like, I can pull the most recent official guidance for your location (New York City) and summarize any eligibility nuances or upcoming eligible groups.
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
www.usnews.comThe CDC has published updated recommendations for older adults, detailing who should get vaccinated against RSV. The move comes after concerns were raised earlier this year that the shot may be linked to a heightened risk of a rare nervous system condition called Guillain-Barré syndrome.
www.webmd.comThe respiratory illness RSV can be serious, especially in children and older adults.
www.cbsnews.comThe forthcoming change from 1 April 2026 will expand the eligibility criteria for the older adult RSV programme to also include those aged 80 years and over (with no upper age limit). Adults aged 75 years and over who have not previously received a single dose of RSV vaccine under the NHS RSV campaign may be offered the vaccine from this point forward. In addition, all residents in care homes for older adults will also become eligible, regardless of their age, due to their increased risk from...
www.gov.ukThe CDC published a new recommendation this week calling for some adults ages 50 to 59 to get vaccinated for respiratory syncytial virus (RSV).
www.webmd.comThe forthcoming change from 1 April 2026 will expand the eligibility criteria for the older adult RSV programme to also include those aged 80 years and over (with no upper age limit). This means all adults aged 75 years and over who have not previously received a single dose of RSV vaccine under the NHS RSV campaign will be eligible for the vaccine from this point forward. In addition, all residents in care homes for older adults will also become eligible, regardless of their age, due to their...
www.gov.ukThe government had accepted advice on eligibility from the Joint Committee on Vaccination and Immunisation for the RSV vaccination programme.
www.wired-gov.netThe RSV vaccine by GSK was previously approved only for adults 60 and older.
www.cbsnews.comThe CDC recommends eligible adults receive a single dose of the RSV vaccine. Learn more about respiratory syncytial virus or schedule your appointment at CVS.
www.cvs.com